Filing Details

Accession Number:
0001209191-11-047115
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-08 16:07:00
Reporting Period:
2011-09-06
Filing Date:
2011-09-08
Accepted Time:
2011-09-08 16:07:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218629 S Leonard Schleifer 777 Old Saw Mill River Road
Tarrytown NY 10591
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-09-06 90 $63.01 810 No 4 S Indirect by Trust for Son
Common Stock Disposition 2011-09-06 180 $65.56 630 No 4 S Indirect by Trust for Son
Common Stock Disposition 2011-09-06 630 $66.54 0 No 4 S Indirect by Trust for Son
Common Stock Acquisiton 2011-09-06 7,000 $0.00 7,000 No 4 C Indirect by Trust for Son
Common Stock Disposition 2011-09-06 3,500 $65.27 3,500 No 4 S Indirect by Trust for Son
Common Stock Disposition 2011-09-06 2,700 $66.42 800 No 4 S Indirect by Trust for Son
Common Stock Disposition 2011-09-06 300 $67.50 500 No 4 S Indirect by Trust for Son
Common Stock Disposition 2011-09-06 500 $68.42 0 No 4 S Indirect by Trust for Son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect by Trust for Son
No 4 S Indirect by Trust for Son
No 4 S Indirect by Trust for Son
No 4 C Indirect by Trust for Son
No 4 S Indirect by Trust for Son
No 4 S Indirect by Trust for Son
No 4 S Indirect by Trust for Son
No 4 S Indirect by Trust for Son
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Class A Stock Disposition 2011-09-06 7,000 $0.00 7,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,275 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 78,765 Direct
Common Stock 100,000 Indirect by GRAT
Common Stock 5,416 Indirect by 401(k) Plan
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Class A Stock $0.00 1,710,790 1,710,790 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
1,710,790 1,710,790 Direct
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 180 shares of Company stock on September 6, 2011 at prices ranging from $65.53 to $65.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  3. Represents volume-weighted average price of sales of 630 shares of Company stock on September 6, 2011 at prices ranging from $66.08 to $66.99.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  4. Shares of Class A Stock are convertible at any time on a share-for-share basis into Common Stock.
  5. Represents volume-weighted average price of sales of 3,500 shares of Company stock on September 6, 2011 at prices ranging from $65.00 to $65.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  6. Represents volume-weighted average price of sales of 2,700 shares of Company stock on September 6, 2011 at prices ranging from $66.03 to $66.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  7. Represents volume-weighted average price of sales of 300 shares of Company stock on September 6, 2011 at prices ranging from $67.25 to $67.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  8. Represents volume-weighted average price of sales of 500 shares of Company stock on September 6, 2011 at prices ranging from $68.15 to $68.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the trust on September 6, 2011 at each separate price.
  9. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.